TW202406551A - 冷凍乾燥組成物(一) - Google Patents

冷凍乾燥組成物(一) Download PDF

Info

Publication number
TW202406551A
TW202406551A TW112115224A TW112115224A TW202406551A TW 202406551 A TW202406551 A TW 202406551A TW 112115224 A TW112115224 A TW 112115224A TW 112115224 A TW112115224 A TW 112115224A TW 202406551 A TW202406551 A TW 202406551A
Authority
TW
Taiwan
Prior art keywords
aqueous composition
pharmaceutically acceptable
acceptable salt
composition
rilpivirine
Prior art date
Application number
TW112115224A
Other languages
English (en)
Chinese (zh)
Inventor
賽門 維奇
米萊安 科隆波
安 德瑟格
馬欣 維斯崔頓
伊溫 維沃特
Original Assignee
愛爾蘭商健生科學愛爾蘭無限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 愛爾蘭商健生科學愛爾蘭無限公司 filed Critical 愛爾蘭商健生科學愛爾蘭無限公司
Publication of TW202406551A publication Critical patent/TW202406551A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
TW112115224A 2022-04-22 2023-04-24 冷凍乾燥組成物(一) TW202406551A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263333557P 2022-04-22 2022-04-22
US63/333,557 2022-04-22
EP22173920.4 2022-05-17
EP22173920 2022-05-17

Publications (1)

Publication Number Publication Date
TW202406551A true TW202406551A (zh) 2024-02-16

Family

ID=86330122

Family Applications (2)

Application Number Title Priority Date Filing Date
TW112115224A TW202406551A (zh) 2022-04-22 2023-04-24 冷凍乾燥組成物(一)
TW112115222A TW202408580A (zh) 2022-04-22 2023-04-24 冷凍乾燥組成物(二)

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW112115222A TW202408580A (zh) 2022-04-22 2023-04-24 冷凍乾燥組成物(二)

Country Status (7)

Country Link
US (1) US20250275967A1 (cg-RX-API-DMAC7.html)
EP (1) EP4511007A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513501A (cg-RX-API-DMAC7.html)
CN (1) CN119403545A (cg-RX-API-DMAC7.html)
CA (1) CA3249784A1 (cg-RX-API-DMAC7.html)
TW (2) TW202406551A (cg-RX-API-DMAC7.html)
WO (2) WO2023203257A1 (cg-RX-API-DMAC7.html)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
EP2330213A1 (en) 2003-03-05 2011-06-08 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
PT3366278T (pt) 2006-06-23 2024-10-21 Janssen Sciences Ireland Unlimited Co Suspensões aquosas de tmc278
BRPI0715113A2 (pt) * 2006-07-26 2013-06-04 Sandoz Ag Sandoz Sa Sandoz Ltd formulaÇço de caspofungina
AR065720A1 (es) * 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
HRP20201241T1 (hr) * 2011-04-15 2020-11-27 Janssen Pharmaceutica N.V. Nanosuspenzije lijeka osušene zamrzavanjem
WO2018013673A1 (en) * 2016-07-13 2018-01-18 Reform Biologics, Llc Stabilizing excipients for therapeutic protein formulations
WO2022109555A1 (en) 2020-11-17 2022-05-27 Janssen Sciences Ireland Unlimited Company Treatment or prevention of hiv infection

Also Published As

Publication number Publication date
EP4511007A1 (en) 2025-02-26
JP2025513501A (ja) 2025-04-24
WO2023203255A1 (en) 2023-10-26
CN119403545A (zh) 2025-02-07
WO2023203257A1 (en) 2023-10-26
US20250275967A1 (en) 2025-09-04
TW202408580A (zh) 2024-03-01
CA3249784A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
ES2989051T3 (es) Suspensiones acuosas de tmc278
JP2009507925A (ja) ナノ粒子タダラフィル製剤
JP2016503030A (ja) 医薬組成物
US20170246118A1 (en) Long acting pharmaceutical compositions
JP2005533056A (ja) 非経口抗真菌生成物
JP2023532981A (ja) 長時間作用型配合物
TW202239408A (zh) 包含二苯基吡𠯤衍生物的醫藥組成物
US20250275967A1 (en) Freeze dried compositions
US20250268896A1 (en) Liquid compositions
KR101811314B1 (ko) Hiv 감염의 치료 및 예방
AU2016219555B2 (en) Aqueous suspensions of TMC278
CN119968203A (zh) 长效配制品